
CNTA
Centessa Pharmaceuticals PLC
Biotechnology
Centessa Pharmaceuticals PLC (CNTA) Stock News
The latest CNTA headlines and market coverage — 1 recent story, updated throughout the day.
- GlobeNewswire Inc.·
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—RAMP, NEE, CNTA, and HCBN
Monteverde & Associates PC is investigating four merger transactions: LiveRamp Holdings' sale to Publicis Groupe for $38.50/share, NextEra Energy's merger with Dominion Energy, Centessa Pharmaceuticals' acquisition by Eli Lilly for $38.00/share plus contingent value rights, and HCB Financial's merger with Independent Bank Corporation. The firm is seeking shareholders to join class action lawsuits related to these deals.